Bridging Radiotherapy & Immunotherapy  | Webversion

Bridging Radiotherapy & Immunotherapy 

September 30th - October 1st 2021, Nijmegen, The Netherlands

To register click here
This international 2-day meeting in Nijmegen, The Netherlands, on September 30th and October 1st 2021 will focus on the combination of radiotherapy and immunotherapy and offers an attractive scientific program with excellent (inter)national speakers.
The majority of cancer patients will undergo radiotherapy during the course of their disease. Combining this local treatment with immunotherapy offers an exciting opportunity to enhance potential systemic effects, which could lead to more successful and less toxic outcomes for many cancer patients.
Additionally, the recent clinical introduction of MR-guided radiotherapy at the Radboudumc will allow for delivering fractions of radiation that are more likely to induce an anti-tumor response than is currently feasible. In depth -Omics analyses, and further integration of (functional) imaging and biomarkers will help to establish what combinations and conditions may be most effective.
We have invited a number of (inter)nationally renowned speakers who will present their latest findings on the following topics:
  • DNA repair and recognition
  • Radio- & immunotherapy
  • Metabolism & Imaging
  • Omics & Radiomics
At the end of day 2, there will be a break-out session for members of the Radio-Immunotherapy and Biomarkers Brain Storm Groups of the Elekta Unity Consortium.

Program day 1 - Thursday 30 September 2021

09:00 - 09:30    Registration and coffee 
09:30 - 09:40   Opening
09:40 - 11:10    Session 1: Setting the scene
11:10 - 11:30    Coffee break
11:30 - 12:40    Session 2: DNA repair and recognition
12:40 - 14:00    Lunch break
14:00 - 15:35    Session 3a: Radio-immunotherapy
14:00 - 12:40
Including a keynote presentation
15:35 - 15:55    Coffee break
15:55 - 17:05    Session 3b: Radio-immunotherapy


Program day 2 - Friday 1 October 2021

08:30 - 10:15    Session 4: Imaging
10:15 - 10:35    Coffee break
10:35 - 12:55    Session 5: Omics & Radiomics
12:55 - 14:00    Lunch break
14:00 - 15:00    Keynote presentation

15:00 - 17:30    Breakout session (by invitation only)

Confirmed speakers

Silvia C. Formenti, New York, US
William H. McBride, Los Angeles, US
Laurent Dercle, New York, US
Simon J. Dovedi, Cambridge, GB
Jerome Galon, Paris, FR
Heidi Lyng, Oslo, NO
Ester Hammond, Oxford, GB
Leika Akkari, Amsterdam, NL
Jake Scott, Ohio, US
Maries van den Broek, Zürich, CH
Jason J. Luke, Pittsburgh, US
Daniel Zips, Tübingen, DE
Bram van Ginneken, Nijmegen, NL
Hugo Aerts, Maastricht, NL
Jannie Borst, Leiden, NL
Sandra Heskamp, Nijmegen, NL
Linda Kerkmeijer, Nijmegen, NL

Organising committee

Prof dr. Marcel Verheij, MD, PhD
Dr. Marleen Ansems, PhD
Dr. Paul N. Span, PhD

Scientific committee

Prof dr. Gosse Adema, PhD
Prof dr. Jan Bussink, MD, PhD
Prof dr. Marcel Verheij, MD, PhD
Prof dr. Hans Kaanders, MD, PhD    
Dr. René Monshouwer, PhD              
Dr. Marleen Ansems, PhD
Dr. Paul N. Span, PhD

Department of Radiation Oncology, Radiotherapy & OncoImmunology laboratory,
Radboudumc, Nijmegen, NL
Click here for the website where you can register for the Early Bird before 1st of September 2021
Radboudumc wapen